Although some people have called it intriguing, a new “On The Horizon” drug, XL-184, is still very early in its testing. What makes LX184 intriguing is the just released results from a conference in Berlin. In very early testing, 19 of 20 men in a phase I trial showed an improvement in their scans used [...]
Remember, tomorrow night is the first annual MEN'S HEALTH NIGHT. Light a blue bulb to honor a man in your life or to remember a man who had been important to you. Brooklyn Borough Hall (Brooklyn New York) will be lit blue in celebration. The Prostate Cancer Coalition of North Carolina has embraced Men's Health [...]
Finally, some good news as Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited have announced their intention to start a Phase III clinical trial of TAK-700 in the U.S. for men with advanced prostate cancer. TAK-700, which I have been writing about under the heading of “On the Horizon,” is [...]
Today, I spent most of the day listening to the CME (Medicare & Medicaid) hearing on Provenge. CME does not have to abide to the decisions of the advisory committee, so like we experienced with the FDA Advisory Committees we will have to wait and see what will eventually become the policy for reimbursement. I [...]
Taking supplements can become confusing. First we hear that a product will help us, it will control our PSA or maybe even cure our cancer. Certain supplements come into vogue; you can’t beat the disease without taking them, almost take them or be square. Then we hear that the product does nothing. It is confusing. [...]